Best cost to buy Stryker

The best cost to buy Stryker (SYK) stock would be at a price that aligns with your investment strategy and risk tolerance. However, based on the current analyst consensus and historical performance, a prudent investor might consider the following factors:

1. Current Analyst Consensus: The average analyst price target for Stryker is $377.82, with a high forecast of $405.00 and a low forecast of $350.00. This suggests that analysts believe the stock has potential for growth from its current price.

2. Historical Performance: Stryker has demonstrated consistent growth, with a 3-year net income compound annual growth rate (CAGR) of 25.99% and a 3-year revenue CAGR of 9.46%. These figures indicate a strong historical performance, which could be used to justify a higher purchase price to capitalize on the company's growth potential.

3. Valuation Metrics: Stryker's price-to-earnings (P/E) ratio is 36.36, price-to-book (P/B) ratio is 6.42, and price-to-sales (P/S) ratio is 5.88. These ratios should be considered in relation to industry norms and the company's growth prospects to determine if the stock is overvalued or undervalued at current prices.

4. Dividend Yield: Stryker has a history of dividend growth, which could be a factor for income-focused investors. The current dividend yield may also be considered in the decision to purchase the stock.
5. Market Conditions: It's important to consider the broader market conditions and investor sentiment at the time of purchase. If the stock has recently experienced a significant price decline or is trading at a lower valuation compared to historical averages, it could present a good entry point for long-term investors.

In conclusion, while the best cost to buy Stryker stock will vary depending on individual circumstances and investment goals, considering the analyst consensus, historical performance, valuation metrics, dividend yield, and market conditions can help investors make an informed decision. It's also advisable to conduct further research and analysis, and to consult with a financial advisor before making any investment decisions.